Cloud-Clone rolls out 5-HT ELISA kit for gut-brain axis research

Cloud-Clone Corp. says its new serotonin ELISA kit is designed to make 5-HT measurement more accurate across serum, tissue and cerebrospinal fluid samples. The launch targets researchers studying the gut-brain axis, neuropsychiatric disease, gastrointestinal disorders and drug screening.

Why it matters: - Serotonin, or 5-hydroxytryptamine (5-HT), is a key signal in the gut-brain axis and a major readout in mood, sleep, digestion and immune research. - Measuring 5-HT is technically difficult because the molecule is easily degraded, present at low levels and vulnerable to interference from similar monoamines. - More reliable 5-HT data can improve disease-model validation, drug screening and studies of psychiatric and gastrointestinal disorders.

What happened: - Cloud-Clone Corp. introduced a 5-HT ELISA kit, Cat. No. CEA808Ge, for research use. - The kit is designed for multi-field serotonin research across human, rat and mouse samples. - The company says the product is aimed at gut-brain axis studies, neuropsychiatric research, gastrointestinal disease models, inflammation work and toxicology screening.

The details: - The kit is built around high-specificity antibodies intended to reduce cross-reactivity with dopamine, norepinephrine and related metabolites. - The assay includes anti-oxidant buffers to help limit sample degradation during dilution and incubation. - The format uses a competitive ELISA workflow with a standard microplate reader. - Validated sample types include serum, plasma, cerebrospinal fluid, brain tissue homogenate, intestinal tissue homogenate and cell-culture supernatant. - Sample preparation is limited to centrifugation and dilution before plate loading. - The full workflow takes about three hours and uses break-apart 96-well plates. - The kit is designed to detect low-level 5-HT changes and to support a broad linear dynamic range. - Matrix-blocking components are intended to reduce non-specific binding from proteins, lipids and ions in complex samples. - Cloud-Clone says batch validation showed favorable intra-assay and inter-assay variation and consistent repeatability. - The company says the kit avoids complicated extraction, purification and derivatization steps.

Between the lines: - The launch reflects a broader market need for assays that are easier to run than chromatography or mass spectrometry but more reliable than generic ELISA kits. - The strongest pitch here is not new biology, but workflow control: preserving fragile analytes while keeping throughput high. - For labs running larger animal cohorts or screening candidate compounds, the combination of speed, low prep and broad sample compatibility is the main selling point.

What's next: - Cloud-Clone is positioning the kit for use in studies of depression, anxiety, insomnia, irritable bowel syndrome, functional dyspepsia, inflammation and drug safety. - The company expects the assay to support both small mechanistic experiments and higher-volume screening programs. - Researchers looking for more information can visit the company's website.

The bottom line: - Cloud-Clone is betting that a more stable, higher-specificity 5-HT ELISA will win over labs that need routine serotonin measurements without the cost and complexity of chromatography or mass spectrometry.